Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 14.21
-0.52 (-3.50%)
May 18, 2026, 2:39 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 4.99 billion as of May 15, 2026. Its market cap has decreased by -47.33% in one year.
Market Cap
4.99B
Enterprise Value
5.48B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.21
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 4.99B, an increase of 3,183.47%. That is a compound annual growth rate of 50.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 4.99B | 31.58% |
| Dec 31, 2025 | 3.79B | -53.95% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 47.20B |
| Mesoblast | 2.73B |
| Neuren Pharmaceuticals | 1.63B |
| PYC Therapeutics | 1.41B |
| Clarity Pharmaceuticals | 1.08B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 481.08M |
| Racura Oncology | 475.23M |